BusinessColibri Heart Valve Continues Enrollment in Clinical Feasibility Study of Second-Generation TAVI SystemBy Nasdaq OMXMay 4, 2018, 3:09 PM UTC
BusinessColibri Heart Valve Advances Second-Generation TAVI System into Clinical Feasibility StudyBy Nasdaq OMXMar 19, 2018, 2:52 PM UTC
BusinessColibri Heart Valve Receives ISO 13485 and EN ISO 13485 CertificationBy Nasdaq OMXMar 3, 2017, 3:00 PM UTC
BusinessColibri Heart Valve Enters Agreement with Venus Medtech to Form Joint Venture to Develop Next-Generation Transcatheter Heart Valve TechnologiesBy Nasdaq OMXSep 13, 2016, 12:00 PM UTC
